Outcomes of RESCUE-RE and the EVT arms of pivotal EVT studies on BAO
| Study | Arm (n) | IVT | mTICI ≥2b | mRS 0–2 | Death | sICH |
| RESCUE-RE 2021 | ||||||
| DEVT arm | 241 | 0 | 181 (75.1) | 63 (26.1) | 63 (26.1) | 21 (8.7) |
| IVT+EVT arm | 69 | 69 (100) | 47 (68.1) | 29 (42.0) | 13 (18.8) | 5 (7.3) |
| BEST 2019 (EVT arm) | 65 | 18 (27.7) | 45 (71.0) | 22 (33.0) | 22 (33.0) | 5 (8.0) |
| BASICS 2021 (EVT arm) | 154 | 121 (78.6) | 63/88* (72.0) | 54 (35.1) | 59 (38.3) | 7 (4.5) |
| BASILAR 2020 (EVT arm) | 647 | 119 (18.4) | 522 (80.7) | 177 (27.4) | 299 (46.2) | 45 (7.1) |
*88 of 154 patients enrolled in the EVT arm of BASICS were analysed.
BAO, acute basilar artery occlusion; BASICS, Basilar Artery International Cooperation Study; BASILAR, EVT for Acute Basilar Artery Occlusion Study; BEST, Endovascular Treatment versus Standard Medical Treatment for Vertebrobasilar Artery Occlusion trial; DEVT, direct endovascular treatment; EVT, endovascular treatment; IVT, intravenous thrombolysis; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction Score; RESCUE-RE, Registration Study for Critical Care of Acute Ischemic Stroke After Recanalization; sICH, symptomatic intracranial haemorrhage.